China Medicine Corporation (CHME)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: May 30, 2025

China Medicine Company Description

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China.

The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds.

It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke.

The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006.

China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

China Medicine Corporation
Country United States
Founded 2005
Industry Medical Distribution
Sector Healthcare
Employees 281
CEO Senshan Yang

Contact Details

Address:
2/F, Guangri Tower
Guangzhou, Nevada 510006
China
Phone 86 20 8739 1718
Website cmc621.com

Stock Details

Ticker Symbol CHME
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US1694911074
SIC Code 2834

Key Executives

Name Position
Senshan Yang Chairman, Chief Executive Officer and Chairman of Guangzhou Konzern Medicine Co., Ltd
Ho Chi Fung Chief Financial Officer
Huizhen Yu Controller